Encompass Health Corp (EHC)
84.49
-0.06
(-0.07%)
USD |
NYSE |
May 24, 16:00
84.48
-0.01
(-0.01%)
Pre-Market: 20:00
Encompass Health SG&A Expense (Quarterly): 775.80M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 775.80M |
December 31, 2023 | 743.40M |
September 30, 2023 | 722.60M |
June 30, 2023 | 705.90M |
March 31, 2023 | 686.20M |
December 31, 2022 | 670.30M |
September 30, 2022 | 655.90M |
June 30, 2022 | 635.90M |
March 31, 2022 | 640.20M |
December 31, 2021 | 632.80M |
September 30, 2021 | 590.40M |
June 30, 2021 | 782.60M |
March 31, 2021 | 746.00M |
December 31, 2020 | -57.60M |
September 30, 2020 | 724.30M |
June 30, 2020 | 715.20M |
March 31, 2020 | 734.90M |
December 31, 2019 | 753.10M |
September 30, 2019 | 735.10M |
June 30, 2019 | 720.30M |
March 31, 2019 | 693.80M |
December 31, 2018 | 687.90M |
September 30, 2018 | 661.80M |
June 30, 2018 | 652.60M |
March 31, 2018 | 649.90M |
Date | Value |
---|---|
December 31, 2017 | 616.40M |
September 30, 2017 | 600.40M |
June 30, 2017 | 598.50M |
March 31, 2017 | 584.50M |
December 31, 2016 | 569.00M |
September 30, 2016 | 545.30M |
June 30, 2016 | 540.10M |
March 31, 2016 | 536.20M |
December 31, 2015 | 519.90M |
September 30, 2015 | 460.60M |
June 30, 2015 | 446.50M |
March 31, 2015 | 434.00M |
December 31, 2014 | 348.90M |
September 30, 2014 | 331.80M |
June 30, 2014 | 327.80M |
March 31, 2014 | 328.90M |
December 31, 2013 | 315.50M |
September 30, 2013 | 314.20M |
June 30, 2013 | 317.20M |
March 31, 2013 | 318.40M |
December 31, 2012 | 315.00M |
September 30, 2012 | 307.50M |
June 30, 2012 | 303.20M |
March 31, 2012 | 307.10M |
December 31, 2011 | 232.10M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
-57.60M
Minimum
Dec 2020
782.60M
Maximum
Jun 2021
665.66M
Average
717.75M
Median
SG&A Expense (Quarterly) Benchmarks
DaVita Inc | 362.48M |
Pediatrix Medical Group Inc | 60.20M |
US Physical Therapy Inc | -- |
The Oncology Institute Inc | 28.45M |
American Oncology Network Inc | 28.28M |